TW326040B - Substituted 5-membered ring heterocycles, their preparation and their use - Google Patents

Substituted 5-membered ring heterocycles, their preparation and their use

Info

Publication number
TW326040B
TW326040B TW083111713A TW83111713A TW326040B TW 326040 B TW326040 B TW 326040B TW 083111713 A TW083111713 A TW 083111713A TW 83111713 A TW83111713 A TW 83111713A TW 326040 B TW326040 B TW 326040B
Authority
TW
Taiwan
Prior art keywords
phenylene
membered ring
substituted
preparation
ring heterocycles
Prior art date
Application number
TW083111713A
Other languages
English (en)
Inventor
Gerhard Zoller
Otmar Klingler
Bernd Jablonka
Melitta Just
Gerhard Breiplhl
Jochen Knolle
Wolfgang Konig
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE4338944A external-priority patent/DE4338944A1/de
Application filed by Hoechst Ag filed Critical Hoechst Ag
Application granted granted Critical
Publication of TW326040B publication Critical patent/TW326040B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
TW083111713A 1993-11-15 1994-12-13 Substituted 5-membered ring heterocycles, their preparation and their use TW326040B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4338944A DE4338944A1 (de) 1993-11-15 1993-11-15 Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
DE4427979A DE4427979A1 (de) 1993-11-15 1994-08-08 Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung

Publications (1)

Publication Number Publication Date
TW326040B true TW326040B (en) 1998-02-01

Family

ID=25931237

Family Applications (1)

Application Number Title Priority Date Filing Date
TW083111713A TW326040B (en) 1993-11-15 1994-12-13 Substituted 5-membered ring heterocycles, their preparation and their use

Country Status (22)

Country Link
US (2) US5981492A (zh)
EP (1) EP0729460B1 (zh)
JP (1) JP3813983B2 (zh)
KR (1) KR100402192B1 (zh)
CN (1) CN1069316C (zh)
AT (1) ATE217615T1 (zh)
AU (1) AU693811B2 (zh)
CA (1) CA2169643A1 (zh)
CY (1) CY2385B1 (zh)
CZ (1) CZ292573B6 (zh)
DE (2) DE4427979A1 (zh)
DK (1) DK0729460T3 (zh)
ES (1) ES2176261T3 (zh)
FI (1) FI113265B (zh)
HU (1) HU223806B1 (zh)
IL (1) IL111622A (zh)
PL (1) PL180906B1 (zh)
PT (1) PT729460E (zh)
RU (1) RU2151143C1 (zh)
SK (1) SK284471B6 (zh)
TW (1) TW326040B (zh)
WO (1) WO1995014008A1 (zh)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung
DE19515177A1 (de) * 1995-04-28 1996-10-31 Cassella Ag Hydantoinderivate als Zwischenprodukte für pharmazeutische Wirkstoffe
JP3895792B2 (ja) 1995-12-08 2007-03-22 プロスケリア・エス・ア・エス 骨形成促進剤
ATE212990T1 (de) 1996-03-20 2002-02-15 Hoechst Ag Inhibitoren der knochenresorption und vitronectinrezeptor-antagonisten
DE19622489A1 (de) * 1996-06-05 1997-12-11 Hoechst Ag Salze des 3-(2-(4-(4-(Amino-imino-methyl)-phenyl)-4- methyl-2,5-dioxo-imidazolidin-1-yl)-acetylamino)-3- phenyl-propionsäure-ethylesters
DE19624604A1 (de) * 1996-06-20 1998-01-02 Hoechst Ag Verfahren zur Herstellung chiraler, nicht racemischer (4-Aryl-2,5-dioxoimidazolidin-1-yl)essigsäuren
DE19629816A1 (de) * 1996-07-24 1998-01-29 Hoechst Ag Neue Cycloalkyl-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
DE19629817A1 (de) * 1996-07-24 1998-01-29 Hoechst Ag Neue Imino-Derivate als Inhibitoren der Knochenresorption und Vitronectinrezeptor-Antagonisten
PL323130A1 (en) * 1996-11-15 1998-05-25 Hoechst Ag Application of heterocyclic compounds in production of a pharmaceutic agent, novel heterocyclic compounds and pharmaceutic agent as such
DE19647381A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag Neue Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
KR100697959B1 (ko) * 1996-11-15 2007-07-09 훽스트 게엠베하 백혈구부착의억제제및vla-4길항제로서의헤테로사이클
DE19647380A1 (de) * 1996-11-15 1998-05-20 Hoechst Ag 5-Ring-Heterocyclen als Inhibitoren der Leukozytenadhäsion und VLA-4-Antagonisten
DE19741235A1 (de) * 1997-09-18 1999-03-25 Hoechst Marion Roussel De Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19741873A1 (de) * 1997-09-23 1999-03-25 Hoechst Marion Roussel De Gmbh Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19751251A1 (de) * 1997-11-19 1999-05-20 Hoechst Marion Roussel De Gmbh Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
DE19821483A1 (de) * 1998-05-14 1999-11-18 Hoechst Marion Roussel De Gmbh Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE19922462A1 (de) 1999-05-17 2000-11-23 Aventis Pharma Gmbh Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
US6624187B1 (en) * 2000-06-12 2003-09-23 Health Research, Inc. Long wave length absorbing bacteriochlorin alkyl ether analogs
DE10111877A1 (de) 2001-03-10 2002-09-12 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10137595A1 (de) 2001-08-01 2003-02-13 Aventis Pharma Gmbh Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
CN107383147A (zh) * 2017-07-14 2017-11-24 广东食品药品职业学院 一种β‑谷甾醇与依帕司他偶联物及其制备方法和用途
WO2019200202A1 (en) * 2018-04-12 2019-10-17 Morphic Therapeutic, Inc. Antagonists of human integrin (alpha4)(beta7)
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof
WO2021076902A1 (en) 2019-10-16 2021-04-22 Morphic Therapeutic, Inc. INHIBITING HUMAN INTEGRIN α 4 β 7
CN117800921B (zh) * 2024-02-28 2024-06-11 南京市鸿舜医药科技有限公司 一种咪唑烷二酮类hdac抑制剂、制备方法及应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3300510A (en) * 1964-03-06 1967-01-24 American Home Prod Hydantoins
DE2714655A1 (de) * 1977-04-01 1978-10-05 Bayer Ag Verfahren zur herstellung von hydantoinen
EP0006352A1 (en) * 1978-06-15 1980-01-09 Beecham Group Plc Hydantoins and thiohydantoins, process for their preparation and pharmaceutical compositions containing them
GB2032419B (en) * 1978-09-05 1983-01-19 Wellcome Found Hydantoin prostaglandin analogues
DE4009506A1 (de) * 1990-03-24 1991-09-26 Hoechst Ag Hydantoinderivate
HUT68769A (en) * 1991-05-07 1995-07-28 Merck & Co Inc FIBRINOGéN RECEPTOR ANTAGONIST COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AS EFFECTIVE SUBSTANCE
DE4126277A1 (de) * 1991-08-08 1993-02-11 Cassella Ag Hydantoinderivate
DE4207254A1 (de) * 1992-03-07 1993-09-09 Cassella Ag 4-oxo-2-thioxoimidazolidin-derivate
DE4213634A1 (de) * 1992-04-24 1993-10-28 Cassella Ag 2,4-Dioxo-imidazolidin-Derivate
DE4224414A1 (de) * 1992-07-24 1994-01-27 Cassella Ag Phenylimidazolidin-derivate, ihre Herstellung und ihre Verwendung
DE4301747A1 (de) * 1993-01-23 1994-07-28 Cassella Ag Substituierte Aminoverbindungen, ihre Herstellung und ihre Verwendung
DE4308034A1 (de) 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
DE4309867A1 (de) 1993-03-26 1994-09-29 Cassella Ag Neue Harnstoffderivate, ihre Herstellung und Verwendung
DE4427979A1 (de) 1993-11-15 1996-02-15 Cassella Ag Substituierte 5-Ring-Heterocyclen, ihre Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
ES2176261T3 (es) 2002-12-01
CZ116296A3 (en) 1996-10-16
ATE217615T1 (de) 2002-06-15
RU2151143C1 (ru) 2000-06-20
SK58596A3 (en) 1997-05-07
DE59410120D1 (de) 2002-06-20
FI113265B (fi) 2004-03-31
JP3813983B2 (ja) 2006-08-23
CN1069316C (zh) 2001-08-08
EP0729460A1 (de) 1996-09-04
DE4427979A1 (de) 1996-02-15
IL111622A (en) 2000-10-31
FI962043A (fi) 1996-05-14
WO1995014008A1 (de) 1995-05-26
PL314306A1 (en) 1996-09-02
FI962043A0 (fi) 1996-05-14
HU9601300D0 (en) 1996-07-29
DK0729460T3 (da) 2002-08-19
HU223806B1 (hu) 2005-01-28
JPH09505062A (ja) 1997-05-20
IL111622A0 (en) 1995-01-24
US6191282B1 (en) 2001-02-20
AU7939794A (en) 1995-06-06
SK284471B6 (sk) 2005-04-01
CN1134696A (zh) 1996-10-30
US5981492A (en) 1999-11-09
CA2169643A1 (en) 1995-05-26
EP0729460B1 (de) 2002-05-15
KR960705786A (ko) 1996-11-08
CZ292573B6 (cs) 2003-10-15
PL180906B1 (pl) 2001-04-30
PT729460E (pt) 2002-10-31
KR100402192B1 (ko) 2004-04-08
AU693811B2 (en) 1998-07-09
HUT74736A (en) 1997-02-28
CY2385B1 (en) 2004-06-04

Similar Documents

Publication Publication Date Title
TW326040B (en) Substituted 5-membered ring heterocycles, their preparation and their use
MX9605128A (es) Nuevos derivados de aminoacidos, procedimientos para su preparacion y composiciones farmaceuticas que contienen estos compuestos.
CA2268954A1 (en) Oxadiazoles, processes for their preparation and their use as medicaments
TR199901765T2 (xx) S�lfomid-metalloproteaz inhibit�rleri
CA2274464A1 (en) Ketobenzamides as calpain inhibitors
EP0528858A4 (en) Inhibitors of dipeptidyl-aminopeptidase type iv
MX9700557A (es) Dihidrobenzofuranos.
EP0048159A3 (en) Novel carboxyalkyl peptides and thioethers and ethers of peptides as antihypertensive agents
HU9501754D0 (en) Dolostatin analog
YU65802A (sh) Derivati azetidina, njihovo dobivanje i farmaceutske smeše koje ih sadrže
ZA988826B (en) Acylsulfamoylbenzamides crop protection compositions comprising them and processes for their preparation
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
HUP0300534A2 (hu) Tumorellenes ekteinaszcidinszármazékok és ezeket tartalmazó gyógyszerkészítmények
DE69730837D1 (de) Indolderivate zur behandlung von osteoporose
ES2131528T3 (es) Nuevos polipeptidos y su uso.
CA2146877A1 (en) Sulphonyl amino carbonyl triazolinones
TR199801268T2 (xx) Ta�ikinin antagonistleri olarak 3-Azetidinilalkilpiperidinler veya pirolidinler.
CA2094806A1 (en) Aminosulfonyl urea acat inhibitors
GR3025117T3 (en) METHOD FOR PREPARING -g(b)-PHENYLISOSERINE AND ANALOGUES THEREOF.
CA2111083A1 (en) Novel peptides, their preparation and use
ATE54666T1 (de) N-substituierte neuraminsaeure-derivate und verfahren zu ihrer herstellung.
CA2051894A1 (en) Substituted 5-Alkoxy-1,2,4-Triazol-3-(Thi)Ones
ATE80388T1 (de) Verfahren zur herstellung von 5-gliedrigen, stickstoffhaltigen heteroaromaten.
WO2000012480A3 (de) Substituierte 3-aryl-pyrazole
HUP0002457A1 (hu) 4-Halogénezett szteroidszármazékok, eljárás előállításukra, ezek intermedierjei, és ezeket tartalmazó gyógyszerkészítmények